-
EP1575582
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1575582
| EP1575582 - COMBINATION THERAPY FOR THE TREATMENT OF ACUTE LEUKEMIA AND MYELODYSPLASTIC SYNDROME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 04.02.2011 Database last updated on 06.07.2024 | Most recent event Tooltip | 04.02.2011 | Application deemed to be withdrawn | published on 09.03.2011 [2011/10] | Applicant(s) | For all designated states Wyeth LLC Five Giralda Farms Madison, NJ 07940 / US | [2010/16] |
| Former [2005/38] | For all designated states Wyeth Five Giralda Farms Madison, New Jersey 07940 / US | Inventor(s) | 01 /
FEINGOLD, Jay, Marshall 230 Indian Creek Road Wynnewood, PA 19096 / US | 02 /
SHERMAN, Matthew Leigh 33 Janet Road Newton, MA 02459 / US | 03 /
BERGER, Mark, Stanley 328 Woodley Road Merion Station PA 19066 / US | 04 /
LEOPOLD, Lance Howard 1441 Catlin Way Dresher, PA 19025 / US | [2008/15] |
| Former [2007/41] | 01 /
FEINGOLD, Jay, Marshall 230 Indian Creek Road Wynnewood, PA 19096 / US | ||
| 02 /
SHERMAN, Leigh, Berger. 33 Janet Road Newton, MA 02459 / US | |||
| 03 /
BERGER, Mark, Stanley 328 Woodley Road Merion Station / US | |||
| 04 /
LEOPOLD, Lance Howard 1441 Catlin Way Dresher, PA 19025 / US | |||
| Former [2005/38] | 01 /
FEINGOLD, Jay, Marshall 230 Indian Creek Road Wynnewood, PA 19096 / US | Representative(s) | Porter, Jonathan Philip, et al ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR | [N/P] |
| Former [2010/26] | Porter, Jonathan Philip, et al Pfizer Limited European Patent Department IPC 748 Ramsgate Road Sandwich, Kent CT13 9NJ / GB | ||
| Former [2005/38] | Denholm, Anna Marie, et al Wyeth Pharmaceuticals, Huntercombe Lane South Taplow, Maidenhead Berkshire SL6 0PH / GB | Application number, filing date | 02784400.0 | 06.11.2002 | [2005/38] | WO2002US35532 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004043461 | Date: | 27.05.2004 | Language: | EN | [2004/22] | Type: | A1 Application with search report | No.: | EP1575582 | Date: | 21.09.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.05.2004 takes the place of the publication of the European patent application. | [2005/38] | Search report(s) | International search report - published on: | US | 27.05.2004 | (Supplementary) European search report - dispatched on: | EP | 10.02.2009 | Classification | IPC: | A61K31/44, A61K31/53, A61K31/70, A61K31/445 | [2005/38] | CPC: |
E05F3/108 (EP);
A61K31/44 (EP);
A61K31/445 (EP);
A61K31/53 (EP);
A61K31/70 (EP);
A61K45/06 (EP);
A61P35/02 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
E05F3/00 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2005/38] | Extension states | AL | Not yet paid | LT | 05.05.2005 | LV | 05.05.2005 | MK | 05.05.2005 | RO | 05.05.2005 | SI | 05.05.2005 | Title | German: | KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON AKUTER LEUKÄMIE UND MYELODYSPLASTISCHER SYNDROME | [2005/38] | English: | COMBINATION THERAPY FOR THE TREATMENT OF ACUTE LEUKEMIA AND MYELODYSPLASTIC SYNDROME | [2005/38] | French: | THERAPIE COMBINEE DE TRAITEMENT DE LA LEUCEMIE AIGUE ET DU SYNDROME MYELODYSPLASIQUE | [2005/38] | Entry into regional phase | 05.05.2005 | National basic fee paid | 05.05.2005 | Search fee paid | 05.05.2005 | Designation fee(s) paid | 05.05.2005 | Examination fee paid | Examination procedure | 05.05.2005 | Amendment by applicant (claims and/or description) | 05.05.2005 | Examination requested [2005/38] | 31.07.2009 | Despatch of a communication from the examining division (Time limit: M06) | 16.04.2010 | Despatch of a communication from the examining division (Time limit: M04) | 27.08.2010 | Application deemed to be withdrawn, date of legal effect [2011/10] | 04.10.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/10] | Fees paid | Renewal fee | 05.05.2005 | Renewal fee patent year 03 | 07.11.2005 | Renewal fee patent year 04 | 06.11.2006 | Renewal fee patent year 05 | 06.11.2007 | Renewal fee patent year 06 | 27.03.2008 | Renewal fee patent year 07 | 06.11.2009 | Renewal fee patent year 08 | 30.11.2010 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO0212347 (IMMUNOMEDICS INC [US], et al); | [A] - AQUINO ET AL, "Acute myelogenous leukemia", CURRENT PROBLEMS IN PEDIATRICS, MOSBY, (20020201), vol. 32, no. 2, ISSN 0045-9380, pages 50 - 58, XP005008704 | [A] - TRAIL P A ET AL, "Monoclonal antibody drug conjugates in the treatment of cancer", CURRENT OPINION IN IMMUNOLOGY, ELSEVIER, OXFORD, GB, (19991001), vol. 11, no. 5, ISSN 0952-7915, pages 584 - 588, XP004257589 DOI: http://dx.doi.org/10.1016/S0952-7915(99)00012-6 | [A] - ERIC L. SIEVERS, "Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates", CANCER CHEMOTHERAPY AND PHARMACOLOGY, (2000), vol. 46, pages S18 - S22, XP002513083 DOI: http://dx.doi.org/10.1007/PL00014043 | International search | [Y]US5744460 ; | [Y]US2002103141 ; | [A] - BERKOW ET AL., Merck Manual of Diagnosis and Therapy, (1997), pages 1242 - 1245, XP002968326 [A] * Section 11, Chapter 138, 17th Edition * | [X] - GARCIA-MANERO, "A phase I study of idarubicin dose escalation with amisfostine and high dose cytarabine in patients wiuth relapsed acute myelogenous leukemia and myelodyspastic syndromes", HAEMATOLOGICA, (200208), vol. 87, no. 8, pages 804 - 807, XP002968327 |